澳洲幸运5www.a55555.net)是澳洲幸运5彩票官方网站,开放澳洲幸运5彩票会员开户、澳洲幸运5彩票代理开户、澳洲幸运5彩票线上投注、澳洲幸运5实时开奖等服务的平台。

,“We are discussing with a few parties at the moment – we can’t reveal this as we have signed the non-disclosure agreement. “We will announce this at a time when we are certain about it. We target to announce this before the year ends,” group managing director Datuk Zulkarnain Md Eusope said at the press briefing on its first quarter financial performance.

PETALING JAYA: Pharmaniaga Bhd aims to announce a merger and acquisition (M&A) deal by the end of the year.

According to the largest pharmaceutical group in the country, it is in talks for such a deal to sustain its financial performance as it will soon normalise from the extraordinary gains that it received during the Covid-19 pandemic.

“We are discussing with a few parties at the moment – we can’t reveal this as we have signed the non-disclosure agreement.

“We will announce this at a time when we are certain about it. We target to announce this before the year ends,” group managing director Datuk Zulkarnain Md Eusope said at the press briefing on its first quarter financial performance.

It is learnt that the group is considering acquiring a fast-moving consumer goods operator and a merger with a pharmaceutical logistics company.

“For us to grow fast in certain areas, we are looking for acquisitions to increase our revenue and profitability – this is our main focus. But at the same time, we are also looking for businesses that are related to what we are doing now,” Zulkarnain said.

“For example, let’s say we would like to acquire a bio-equivalent company – it is because whenever we produce a generic drug, we have to conduct a bio-equivalent study.

“We can have a more complete value chain if we have this capability (in-house). This is just an example,” he said.

The group is also able to depend on its consumer healthcare segment, which includes supplements, to support sales.

Meanwhile, the group is in “very serious discussions” to sell its Covid-19 vaccines to the African continent which has a population of 1.2 billion.

“The vaccination rates there are very low – in some areas it is not even 5% or 20%. We are discussing with the International Islamic Development Bank which can assist the Organisation of Islamic Cooperation countries in Africa,” he said.

“Seven embassies from the African nations had met us to discuss about this. If this is successful, then our revenues for this financial year (FY) will be similar to FY21,” Zulkarnain added.

The group is also able to depend on its consumer healthcare segment, which includes supplements, to support sales.

飞机群组声明:该文看法仅代表作者自己,与本平台无关。转载请注明:澳洲幸运5(www.a55555.net)_M&A on the cards for Pharmaniaga
发布评论

分享到:

免费足球预测(www.hgbbs.vip)_Bitcoin stems heavy losses but pessimism reigns in crypto markets
你是第一个吃螃蟹的人
发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。